The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma: A 10-Year, Single-Institution Cohort Study
Abstract
IMPORTANCE: Although most cases of cutaneous squamous cell carcinoma (CSCC) are easily cured with surgery or ablation, a subset of these tumors recur, metastasize, and cause death. We conducted the largest study of CSCC outcomes since 1968. OBJECTIVE: To identify risk factors independently associated with poor outcomes in primary CSCC. DESIGN: A 10-year retrospective cohort study. SETTING: An academic hospital in Boston. PARTICIPANTS: Nine hundred eighty-five patients with 1832 tumors. MAIN OUTCOMES AND MEASURES: Subhazard ratios for local recurrence, nodal metastasis, disease-specific death, and all-cause death adjusted for presence of known prognostic risk factors. RESULTS: The median follow-up was 50 (range, 2-142) months. Local recurrence occurred in 45 patients (4.6%) during the study period; 36 (3.7%) developed nodal metastases; and 21 (2.1%) died of CSCC. In multivariate competing risk analyses, independent predictors for nodal metastasis and disease-specific death were a tumor diameter of at least 2 cm (subhazard ratios, 7.0 [95% CI, 2.2-21.6] and 15.9 [4.8-52.3], respectively), poor differentiation (6.1 [2.5-14.9] and 6.7 [2.7-16.5], respectively), invasion beyond fat (9.3 [2.8-31.1] and 13.0 [4.3-40.0], respectively), and ear or temple location (3.8 [1.1-13.4] and 5.9 [1.3-26.7], respectively). Perineural invasion was also associated with disease-specific death (subhazard ratio, 3.6 [95% CI, 1.1-12.0]), as was anogenital location, but few cases were anogenital. Overall death was associated with poor differentiation (subhazard ratio, 1.3 [95% CI, 1.1-1.6]) and invasion beyond fat (1.7 [1.1-2.8]). CONCLUSIONS AND RELEVANCE: Cutaneous squamous cell carcinoma carries a low but significant risk of metastasis and death. In this study, patients with CSCC had a 3.7% risk of metastasis and 2.1% risk of disease-specific death. Tumor diameter of at least 2 cm, invasion beyond fat, poor differentiation, perineural invasion, and ear, temple, or anogenital location were risk factors associated with poor outcomes. Accurate risk estimation of outcomes from population-based data and clinical trials proving the utility of disease-staging modalities and adjuvant therapy is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
The Statistical Analysis of Failure Time Data
Klein, J. P. (1982) · Technometrics · doi:10.1080/00401706.1982.10487769 · Cited by 2,215
Rowe, D. E., Carroll, R. J., & Day, C. L. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(92)70144-5 · Cited by 1,503
Nonmelanoma skin cancer in the United States: Incidence
Miller, D. L., & Weinstock, M. A. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81509-5 · Cited by 1,098
Brantsch, K. D., Meisner, C., Schönfisch, B., Trilling, B., Wehner-Caroli, J., Röcken, M., & Breuninger, H. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70178-5 · Cited by 1,054
The Statistical Analysis of Failure Time Data
Borgan, Ø. (2003) · Journal of the American Statistical Association · doi:10.1198/jasa.2003.s310 · Cited by 799
Mortality Risk From Squamous Cell Skin Cancer
Clayman, G. L., Lee, J. J., Holsinger, F. C., Zhou, X., Duvic, M., El-Naggar, A. K., Prieto, V. G., Altamirano, E., Tucker, S. L., Strom, S. S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.155 · Cited by 392
Veness, M. J., Morgan, G. J., Palme, C. E., & Gebski, V. (2005) · The Laryngoscope · doi:10.1097/01.mlg.0000158349.64337.ed · Cited by 295
Metastatic Cutaneous Squamous Cell Carcinoma: An Update
WEINBERG, A. S., OGLE, C. A., & SHIM, E. K. (2007) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2007.33190.x · Cited by 200
Cutaneous head and neck SCCs and risk of nodal metastasis – UK experience
Mourouzis, C., Boynton, A., Grant, J., Umar, T., Wilson, A., Macpheson, D., & Pratt, C. (2009) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2009.07.007 · Cited by 167
Cited by
Lydiatt, W. M., Patel, S. G., O'Sullivan, B., Brandwein, M. S., Ridge, J. A., Migliacci, J. C., Loomis, A. M., & Shah, J. P. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21389 · Cited by 1,625
Karia, P. S., Han, J., & Schmults, C. D. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.11.037 · Cited by 829
Self-citationMutational landscape of aggressive cutaneous squamous cell carcinoma
Pickering, C. R., Zhou, J. H., Lee, J. J., Drummond, J. A., Peng, S. A., Saade, R. E., Tsai, K. Y., Curry, J. L., Tetzlaff, M. T., Lai, S. Y., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1768 · Cited by 612
Thompson, A. K., Kelley, B. F., Prokop, L. J., Murad, M. H., & Baum, C. L. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.4994 · Cited by 521
Cutaneous Squamous Cell Carcinoma
Waldman, A., & Schmults, C. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.08.001 · Cited by 424
Self-citation
Metadata
- Authors
- Schmults, C. D., Karia, P. S., Carter, J. B., Han, J., & Qureshi, A. A.
- Venue
- JAMA Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2013-05-01
- Volume
- 149
- Issue
- 5
- Pages
- 541
- ISSN
- 2168-6068 (ISSN-L)
- OpenAlex
- W2059179724
- Cited by
- 571
- References
- 15
- FWCI
- 15.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma: A 10-Year, Single-Institution Cohort Study. https://app.cochat.ai/papers/10.1001/jamadermatol.2013.2139
- The paper
- Schmults, C. D., Karia, P. S., Carter, J. B., Han, J., & Qureshi, A. A. (2013). Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma: A 10-Year, Single-Institution Cohort Study. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2013.2139
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.